Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × pyrotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 54 HER2-positive Breast Cancer 15 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 4 HER2 Positive Metastatic Breast Cancer 3 HER2 Positive Breast Cancer 3 Breast Diseases 3 Advanced Breast Cancer 3 Colorectal Neoplasms 2 Breast Cancer Invasive 2 Breast Cancer Female 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Salivary Gland Neoplasms 1 Rare Tumour 1 Rare Tumor 1 Pathologic Complete Response 1 Non-squamous NSCLC 1 Non Small Cell Lung 1 Neoplasm Metastasis 1 Metastatic Breast Cancer in the Brain 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 HER2-expressing Advanced Solid Tumors 1 HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane 1 HER2+ Early or Locally Advanced Breast Cancer 1

Interventions

Carboplatin 276 Cisplatin 205 Radiotherapy 182 Paclitaxel 166 Pemetrexed 155 Docetaxel 143 Gemcitabine 132 pembrolizumab 123 Erlotinib Hydrochloride 92 Magnetic Resonance Spectroscopy 89 Etoposide 82 Bevacizumab 74 Specimen Handling 70 Radiosurgery 63 Nivolumab 63 durvalumab 61 Vinorelbine 48 osimertinib 47 Drug Therapy 46 Blood Specimen Collection 44 Gefitinib 40 atezolizumab 37 Surveys and Questionnaires 37 Biopsy 36 Topotecan 35 Irinotecan 35 Radiation 34 Cyclophosphamide 34 Standard of Care 32 Surgical Procedures, Operative 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06563999 2024-12-10

NUMER

Sun Yat-sen University

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡